Published in Int J Radiat Oncol Biol Phys on October 12, 1982
In vivo assessment of basic 2-nitroimidazole radiosensitizers. Br J Cancer (1982) 1.00
A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo. Br J Cancer (1982) 0.79
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys (2000) 7.50
More on managing metastatic choroidal tumors. Oncology (Williston Park) (1989) 5.12
Noncontact anterior cruciate ligament injuries: risk factors and prevention strategies. J Am Acad Orthop Surg (2000) 4.61
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol (2000) 3.24
Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect Immun (1994) 2.73
Local hyperthermia in combination with definitive radiotherapy: increased tumor clearance, reduced recurrence rate in extended follow-up. Int J Radiat Oncol Biol Phys (1984) 2.72
In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci. Antimicrob Agents Chemother (1996) 2.63
Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out. J Clin Oncol (1996) 2.56
Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative. Radiology (1977) 2.55
Plasmacytoma. Treatment results and conversion to myeloma. Cancer (1992) 2.50
Factors effecting late results after meniscectomy. J Bone Joint Surg Am (1974) 2.49
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol (1999) 2.48
Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond) (2009) 2.39
Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med (1988) 2.26
Improved methodology for analyzing local and distant recurrence. J Clin Oncol (1990) 2.21
The use of health services by older adults. J Gerontol (1991) 2.18
Prospective study of follow up alone in stage I teratoma of the testis. Br Med J (Clin Res Ed) (1983) 2.13
Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors. Int J Radiat Oncol Biol Phys (1993) 2.13
Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis. Cancer (1993) 2.07
Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys (1992) 2.05
American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol (1999) 2.03
Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int (1992) 2.02
Mechanical changes in the knee after meniscectomy. J Bone Joint Surg Am (1976) 2.00
Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat Res (1993) 1.99
Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol (2001) 1.98
Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol (1995) 1.96
Strain within the anterior cruciate ligament during hamstring and quadriceps activity. Am J Sports Med (1986) 1.95
Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys (1997) 1.93
Hematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med (1977) 1.93
Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest (1994) 1.91
Phase 1 study of high-dose metronidazole: a specific in vivo and in vitro radiosensitizer of hypoxic cells. Radiology (1975) 1.90
Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol (2001) 1.90
Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys (2000) 1.87
Letter: "High-dose" metronidazole: a preliminary pharmacological study prior to its investigational use in clinical radiotherapy trials. Br J Radiol (1974) 1.87
Trends in skiing injuries. Analysis of a 6-year study (1972 to 1978). Am J Sports Med (1980) 1.86
The risk of nursing home placement and subsequent death among older adults. J Gerontol (1992) 1.86
Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol (1998) 1.83
Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest (1994) 1.83
A "weight-listing" paradox for candidates of renal transplantation? Am J Transplant (2006) 1.75
New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest (1987) 1.75
Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int (2001) 1.75
The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol (1988) 1.73
Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience. Ann Surg (1994) 1.72
Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int (2000) 1.72
Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys (1995) 1.71
Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res (1993) 1.71
Changes in functional status and the risks of subsequent nursing home placement and death. J Gerontol (1993) 1.71
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1998) 1.71
Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys (1994) 1.70
Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am (2006) 1.70
The strain behavior of the anterior cruciate ligament during squatting and active flexion-extension. A comparison of an open and a closed kinetic chain exercise. Am J Sports Med (1998) 1.68
Uveal melanoma. Growth rate and prognosis. Arch Ophthalmol (1997) 1.67
Perceived health status and mortality among older men and women. J Gerontol (1992) 1.67
Gastrostomy insertion: comparing the options--PEG, RIG or PIG? Clin Radiol (2003) 1.67
Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. Kidney Int (2007) 1.66
Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys (1998) 1.66
Heat shock proteins and thermotolerance; a comparison of induction kinetics. Br J Radiol (1982) 1.64
Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am (1998) 1.63
Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest (1993) 1.63
Anterior cruciate ligament strain behavior during rehabilitation exercises in vivo. Am J Sports Med (1995) 1.63
A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys (1991) 1.63
Persistent Campylobacter jejuni infection in an immunocompromised patient. Ann Intern Med (1984) 1.62
Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene (1999) 1.62
Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int (1991) 1.61
Horner syndrome occurring as a complication of chest tube placement. Radiology (1987) 1.60
Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int (1999) 1.60
Transport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer's patch. Cell Tissue Res (1987) 1.59
Public health oncology: a framework for progress in low- and middle-income countries. Ann Oncol (2012) 1.59
A method to help reduce the risk of serious knee sprains incurred in alpine skiing. Am J Sports Med (1996) 1.58
RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys (1995) 1.57
High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys (1990) 1.56
Urinary tract obstruction and nephrostomy drainage in pelvic malignant disease. Br J Urol (1995) 1.54
The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion. Eye (Lond) (2003) 1.53
Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis (2001) 1.52
An electrogoniometric study of knee motion in normal gait. J Bone Joint Surg Am (1970) 1.51
The biomechanics of anterior cruciate ligament rehabilitation and reconstruction. Am J Sports Med (1984) 1.50
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int (2001) 1.50
The effect of weightbearing and external loading on anterior cruciate ligament strain. J Biomech (2001) 1.50
Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys (1999) 1.50
Biocompatibility of hemodialysis membranes: evaluation in an ovine model. J Lab Clin Med (1993) 1.46
Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int (1992) 1.46
Identification of an endotoxin and IFN-inducible cDNA: possible identification of a novel protein family. J Leukoc Biol (1995) 1.45
Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. Br J Haematol (1997) 1.45
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol (1999) 1.45
Downhill skiing injuries in children. Am J Sports Med (1984) 1.45
Overuse injuries in sports. A review. Sports Med (1985) 1.44
Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Cancer Res (1994) 1.44
Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int (1996) 1.43
Prognostic factors for patients with Hodgkin disease in first relapse. Cancer (1993) 1.42
Failure of preenucleation radiation to decrease uveal melanoma mortality. Am J Ophthalmol (1988) 1.42
Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest (1986) 1.42
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol (2001) 1.42
Peripheral neuropathy related to misonidazole: incidence and pathology. Br J Cancer Suppl (1978) 1.42
Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol (1995) 1.41
Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int (1995) 1.41
Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int (2006) 1.40
Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy. Kidney Int (2001) 1.40